391 related articles for article (PubMed ID: 3338012)
1. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
2. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
Pinto AE; André S; Soares J
J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231
[TBL] [Abstract][Full Text] [Related]
3. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
4. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting.
Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM
Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161
[TBL] [Abstract][Full Text] [Related]
5. A proposed classification of breast cancer based on kinetic information: derived from a comparison of risk factors in 168 primary operable breast cancers.
McDivitt RW; Stone KR; Craig RB; Palmer JO; Meyer JS; Bauer WC
Cancer; 1986 Jan; 57(2):269-76. PubMed ID: 3942959
[TBL] [Abstract][Full Text] [Related]
6. Relationships of DNA ploidy, S-phase fraction and hormone receptor status to tumor stage in breast cancers detected by population screening. The South-East Sweden Breast Cancer Group.
Stål O; Brisfors A; Carstensen J; Ferraud L; Hatschek T; Nordenskjöld B
Int J Cancer; 1992 Apr; 51(1):28-33. PubMed ID: 1563841
[TBL] [Abstract][Full Text] [Related]
7. Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.
Kallioniemi OP; Blanco G; Alavaikko M; Hietanen T; Mattila J; Lauslahti K; Lehtinen M; Koivula T
Cancer; 1988 Nov; 62(10):2183-90. PubMed ID: 3179930
[TBL] [Abstract][Full Text] [Related]
8. Practical breast carcinoma cell kinetics: review and update.
Meyer JS; McDivitt RW; Stone KR; Prey MU; Bauer WC
Breast Cancer Res Treat; 1984; 4(2):79-88. PubMed ID: 6378283
[TBL] [Abstract][Full Text] [Related]
9. A novel flow cytometric steroid hormone receptor assay for paraffin-embedded breast carcinomas: an objective quantification of the steroid hormone receptors and direct correlation to ploidy status and proliferative capacity in a single-tube assay.
Leers MP; Schutte B; Theunissen PH; Ramaekers FC; Nap M
Hum Pathol; 2000 May; 31(5):584-92. PubMed ID: 10836298
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient.
Haffty BG; Toth M; Flynn S; Fischer D; Carter D
J Clin Oncol; 1992 Dec; 10(12):1839-47. PubMed ID: 1453198
[TBL] [Abstract][Full Text] [Related]
11. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.
Clark GM; Dressler LG; Owens MA; Pounds G; Oldaker T; McGuire WL
N Engl J Med; 1989 Mar; 320(10):627-33. PubMed ID: 2918874
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
Leers MP; Nap M
Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of S-phase fraction and DNA ploidy studied with in vivo administration of bromodeoxyuridine on human gastric cancers.
Ohyama S; Yonemura Y; Miyazaki I
Cancer; 1990 Jan; 65(1):116-21. PubMed ID: 2293858
[TBL] [Abstract][Full Text] [Related]
14. Independent prognostic value of hormone receptor expression and S-phase fraction in advanced breast cancer.
Pinto AE; Mendonça E; André S; Nóbrega SD; Soares J
Anal Quant Cytol Histol; 2002 Dec; 24(6):345-54. PubMed ID: 12508694
[TBL] [Abstract][Full Text] [Related]
15. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
Meyer JS; Province MA
Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
[TBL] [Abstract][Full Text] [Related]
16. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
[TBL] [Abstract][Full Text] [Related]
17. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
[TBL] [Abstract][Full Text] [Related]
18. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.
Kute TE; Muss HB; Hopkins M; Marshall R; Case D; Kammire L
Breast Cancer Res Treat; 1985; 6(2):113-21. PubMed ID: 4052638
[TBL] [Abstract][Full Text] [Related]
19. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma.
Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML
Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770
[TBL] [Abstract][Full Text] [Related]
20. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
